Stockreport

Rare disease developers applaud clarity in FDA guidance [Yahoo! Finance]

INNOVATIVE DESIGNS INC  (IVDN) 
NASDAQ:AMEX Investor Relations: investors.verabradley.com/investor-relations
PDF US Food and Drug Administration (FDA) over the past year, have delivered much-needed clarity on regulatory expectations, including what is and what is not permissible. [Read more]